Asuragen Lands $7,500,000 New Funding Round

  • Feed Type
  • Date
    3/21/2013
  • Company Name
    Asuragen
  • Mailing Address
    2150 Woodward St. Austin, TX 78744
  • Company Description
    Asuragen has its roots in Ambion, ‘The RNA Company.’ Ambion is a molecular biology reagent company with a strong focus on RNA. Asuragen is the successor entity to Ambion.
  • Website
    http://www.asuragen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy